Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR -2.24%67 Operating Margin % is 20.71% as of Mar. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 67/100 and a GF Value™ of kr2.35 (Modestly Overvalued). Among 816 Medical Devices & Instruments companies, Medclair AB ranks better than 64.22% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Medclair AB's Operating Income for the
three
months ended in Mar. 2026 was kr3.78 Mil. Medclair AB's Revenue for the
three
months ended in Mar. 2026 was kr18.24 Mil. Therefore, Medclair AB's Operating Margin % for the quarter that ended in Mar. 2026 was 20.71%.
The historical rank and industry rank for Medclair AB's Operating Margin % or its related term are showing as below:
NGM:MCLR'
s Operating Margin % Range Over the Past 10 Years
Min: -128.44 Med: -25.05 Max: 11.84
Current: 9.05
NGM:MCLR's Operating Margin % is ranked better than 64.22% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.28
vs NGM:MCLR: 9.05
Medclair AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Medclair AB's Operating Income for the
three
months ended in Mar. 2026 was kr3.78 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr4.95 Mil.
Medclair AB (NGM:MCLR) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Medclair AB Operating Margin % Related Terms
Medclair AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for Medclair AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:MCLR vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, Medclair AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Medclair AB's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Medclair AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medclair AB (NGM:MCLR) has a Operating Margin % of 20.71% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Medclair AB and its competitors. According to the industry distribution chart, Medclair AB ranks #292 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 35.8%.
Is Medclair AB's Operating Margin % too high?
Medclair AB's current Operating Margin % is 20.71%. The Medical Devices & Instruments industry median Operating Margin % is 3.28. Medclair AB's value of 20.71% is 531.4% above this industry median. Based on the distribution chart, Medclair AB ranks #292 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medclair AB has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #292 out of 816 companies for Operating Margin %. This puts Medclair AB in the upper half of its industry. The industry median Operating Margin % is 3.28. Medclair AB's value of 20.71% is 531.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.28, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medclair AB's current Operating Margin % of 20.71% is 531.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Medclair AB and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medclair AB's current Operating Margin % is 20.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Modestly Overvalued. The stock's GF Value™ is kr2.35, compared to a current price of kr3.05 — trading 29.8% above its estimated fair value. The current Operating Margin % is 20.71% and 531.4% above the Medical Devices & Instruments industry median of 3.28. Medclair AB's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Operating Margin % is 20.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr3.05 is trading 29.8% above its estimated GF Value™ of kr2.35.
GuruFocus considers Medclair AB to be Modestly Overvalued.
Key valuation signals for NGM:MCLR:
Operating Margin %: 20.71%
GF Value™: kr2.35 vs. price of kr3.05 (29.8% above fair value)
Industry Position: 531.4% above the Medical Devices & Instruments median (#292 of 816)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
67GF Score
Get the complete analysis for NGM:MCLR
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
